Jasper Therapeutics Inc (JSPR)
22.45
-2.07
(-8.44%)
USD |
NASDAQ |
May 06, 16:00
22.45
0.00 (0.00%)
After-Hours: 20:00
Jasper Therapeutics Shareholders Equity (Quarterly): 78.44M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 78.44M |
| September 30, 2023 | 94.13M |
| June 30, 2023 | 110.20M |
| March 31, 2023 | 125.20M |
| December 31, 2022 | 35.99M |
| September 30, 2022 | 47.56M |
| Date | Value |
|---|---|
| June 30, 2022 | 58.78M |
| March 31, 2022 | 68.10M |
| December 31, 2021 | 69.52M |
| September 30, 2021 | 78.60M |
| December 31, 2020 | -35.13M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-35.13M
Minimum
Dec 2020
125.20M
Maximum
Mar 2023
66.49M
Average
69.52M
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 405.33M |
| Equillium Inc | 22.57M |
| Akero Therapeutics Inc | 535.31M |
| 89bio Inc | 536.31M |
| PepGen Inc | 108.42M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 94.89M |
| Total Liabilities (Quarterly) | 16.45M |